Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 9 , ISSUE 2 ( April-June (with Supplement), 2017 ) > List of Articles

RESEARCH ARTICLE

Seroprevalence of Hepatitis B Surface Antigen among Pregnant Women in a Tertiary Care Health Center of North India

Rekha Rani, Asha Nigam

Citation Information : Rani R, Nigam A. Seroprevalence of Hepatitis B Surface Antigen among Pregnant Women in a Tertiary Care Health Center of North India. J South Asian Feder Obs Gynae 2017; 9 (2):164-168.

DOI: 10.5005/jp-journals-10006-1484

Published Online: 01-04-2017

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

PDF Share
  1. Hepatitis B. World Health Organization Fact Sheet No 204. World Health Organization; 2014 July [cited 2014 Dec 07]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
  2. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005 Dec;34(6):1329-1339.
  3. Hepatitis B: World Health Organization Fact Sheet 204. World Health Organization; 2000 [Cited 2000 Dec]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
  4. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trail. Pediatrics 1985 Nov;76(5):713-718.
  5. Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant in India. J Med Virol 2011 Jun;83(6):962-967.
  6. Prevalence of hepatitis B surface antigen in pregnant mothers and its transmission. Trans R Soc Trop Med Hyg 1989 Sep-Oct;83(5):698-700.
  7. Hepatitis B – potential of perinatal transmission in India. Trop Gastroenterol1996 Jul-Sep;17(3);190-192.
  8. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol 1987 Feb;21(2):137-145.
  9. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011 Mar;30(2):66-71.
  10. HBeAg and anti-HBe detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979 Jan;3(3):237-241.
  11. A molecular epidemiology study on risk factors and mechanism of HBV intrauterine transmission. Zhonghua Yi Xue Za Zhi 1999 Jan;79(1):24-27.
  12. The role of placenta in hepatitis B virus intrauterine transmission. Zhonghua Fu Chan Ke Za Zhi 1999 Jul;34(7):392-395.
  13. A molecular epidemiologic study on the mechanism of intrauterine transmission of hepatitis B virus. Zhonghua Liu Xing Bing Xue Za Zhi 1998 Jun;19(3):131-133.
  14. Role of placental tissues in the in the intrauterine transmission of hepatitis B virus. Am J Obstet Gynecol 2001 Oct;185(4):981-987.
  15. Viral hepatitis in India. Clin Lab Med 2012 Jun;32(2):159-174.
  16. Prevention of hepatitis B in India – an overview. World Health Organization South-East Asia Regional Office; New Delhi: World Health Organization; 2002.
  17. Hepatitis B in India. A review of disease epidemiology. Indian Pediatr 2001 Apr;38(4):349-371.
  18. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000 Dec;15(12):1356-1361.
  19. Prevalence, correlates and pattern of hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth 2013 Aug,13(1):158. Available from: http://www.biomedcentral.com/1471-2393/13/158.
  20. Sero-prevalence of hepatitis B surface antigen among pregnant women attending Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Nigerian J Parasitol 2008;29(1):38-41.
  21. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J 2011 Jan;8:12.
  22. Hepatitis B viral markers in Ghanaian pregnant women. West Afr J Med 1994 Jul-Sep;13(3):134-137.
  23. Prevalence of hepatitis B viral markers in a population of pregnant women in Brazzaville (Congo). J Gynecol Obstet Biol Reprod (Paris) 1995 Feb;24(5):534-536.
  24. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J 2006 Sep;83(9):485-493.
  25. HBs antigen carrier state in pregnant women in Bobo Dioulasso (Burkina Faso). Dakar Med 2000 Feb;45(2):188-190.
  26. A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon. Virol J 2012 Mar;9(1):62.
  27. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross sectional study in two hospitals in northern Uganda. BMJ Open 2014 Nov;4(11):e005889.
  28. Seroprevalence of hepatitis B virus infection among antenatal clinic attendees at a tertiary hospital in Dar es salaam, Tanzania. Tanzan J Health Res 2014 Jan;16(1):9-15.
  29. An assessment of hepatitis B introduction in India: lessons for roll out and scale up of new vaccines in immunization programs. Indian J Public Health 2013 Jan-Mar;57(1):8-14.
  30. Seroprevalence of hepatitis B and C and HIV in Malawian Pregnant women. J Infect 1998 Nov;37(3):248-251.
  31. A comparison of human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenemia (HBsAg) among the same group of apparently healthy pregnant women in Lagos, Nigeria: a preliminary report. Viral Immunol 1993 Spring;6(1):43-47.
  32. ; Naik, SR. Cost efficacy evaluation of inclusion of hepatitis-B vaccine in expanded programme of immunization. In: Sarin SK, Singhal AK, editors. Hepatitis B in India. Delhi: CBS Publishers and Distributors;. 1996. p. 206-216.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.